Literature DB >> 8513857

Interpretation of chloroquine pharmacokinetic data.

A McLachlan, S Tett, R Day, D Cutler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8513857     DOI： 10.1007/BF00316484

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  9 in total

1.  Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques.

Authors:  S E Tett; D J Cutler; R O Day
Journal:  J Pharm Sci       Date:  1992-02       Impact factor: 3.534

2.  Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times.

Authors:  S E Tett; D J Cutler
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Enantioselective analysis of chloroquine and desethylchloroquine after oral administration of racemic chloroquine.

Authors:  D Ofori-Adjei; O Ericsson; B Lindström; J Hermansson; K Adjepon-Yamoah; F Sjöqvist
Journal:  Ther Drug Monit       Date:  1986       Impact factor: 3.681

4.  The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects.

Authors:  M Frisk-Holmberg; Y Bergqvist; E Termond; B Domeij-Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Characteristics of chloroquine binding to glass and plastic.

Authors:  T G Geary; M A Akood; J B Jensen
Journal:  Am J Trop Med Hyg       Date:  1983-01       Impact factor: 2.345

6.  A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers.

Authors:  S E Tett; D J Cutler; R O Day; K F Brown
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

7.  Disposition of chloroquine in man after single intravenous and oral doses.

Authors:  L L Gustafsson; O Walker; G Alván; B Beermann; F Estevez; L Gleisner; B Lindström; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

8.  Bioavailability of hydroxychloroquine tablets in healthy volunteers.

Authors:  S E Tett; D J Cutler; R O Day; K F Brown
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

9.  Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis.

Authors:  P Augustijns; P Geusens; N Verbeke
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.